Phase I/II Study of Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone (BelCyd) in Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Badros, Ashraf Z. ^{[1
]}

Nash, Thea ^{[2
]}

Lawrance, Christopher ^{[2
]}

Tittle, Brandon ^{[2
]}

Philip, Sunita ^{[3
]}

Sunshine, Sarah ^{[4
]}

Munir, Wuqaas ^{[4
]}

Fan, Xiaoxuan ^{[5
]}

Ide, Christina ^{[2
]}

Atanackovic, Djordje ^{[3
]}

机构：

[1] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[2] Univ Maryland, Sch Med, Greenebaum Canc Canter, Baltimore, MD 21201 USA

[3] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[4] Univ Maryland, Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA

[5] Univ Maryland, Sch Med, Flow Cytometry Shared Serv, Baltimore, MD 21201 USA

来源：

关键词：

D O I：

10.1182/blood-2023-182254

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3